查看购物车
  • Traditional Chinese
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2003238

人工水晶体市场（2026）：2025年至2031年全球市场分析

2026 IOL Market Report: Global Analysis for 2025 to 2031
出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

什么是新的：

《2026 年人工水晶体市场报告》是迄今为止最全面、最具策略性洞察力的版本，其中包含更详细的区域分析、新的技术资讯以及对重塑全球白内障市场的结构性因素的广泛评估。

今年的报告全面概​​述了2025年八大区域类别的发展趋势，重点在于关键事件、竞争格局变化、价格趋势和市场动态。此外，报告还按单焦点人工晶体、老花眼矫正晶体、散光矫正晶体和其他人工水晶体对六年期间（2019-2025年）的销售业绩进行了分类，从而更清晰地展现了各细分市场的增长情况以及高级产品组合的变化。

2026 年的报告新增了一个章节，检验人工智慧 (AI) 在人工水晶体) 设计中日益广泛的应用及其对性能的潜在影响。报告还涵盖了中小製造商采用的基于分销商的打入市场策略的优势和局限性（包括确定各地区的关键分销商）、新兴的人工水晶体材料（例如 Eyedeal 等基于 SIBS 的平台）以及更广泛的市场因素，例如干眼症管理如何优化人工水晶体术后效果，以及预计对白内障手术数量的潜在影响。

《2026 年人工水晶体市场报告》结合了对当前市场状况的详细分析和五年预测，以帮助制定策略、投资和竞争定位，从而提供全球人工水晶体市场的全面和数据驱动的观点。

本报告基于 Market Scope 的专有模型和深入的行业洞察，识别出影响需求的趋势，追踪技术采用的发展，并重点介绍了在竞争日益激烈和创新主导的市场中决定成功的因素。

本报告将市场细分为 11 个不同的 IOL 类别（通用单焦点、增强型单焦点/中程优化单焦点、散光、PC 散光、双焦点、三焦点、扩展景深 (EDOF)、EDOF 多重焦点混合型、调节型、术后可调型和有晶体眼 IOL），从而分析市场，清楚地展示了成长发生在哪里以及高端市场如何继续发展。

此外，本报告分析了 40 家主要企业，深入分析了它们的产品系列、战略定位、竞争优势和未来前景，提供了与竞争对手进行基准比较以及在全球 IOL 市场中识别商机所需的必要资讯。

目录：

《2026 年人工水晶体市场报告》透过对八个主要地区的白内障和人工水晶体市场进行可操作的分析，提供了前所未有的全球展望，该分析整合了手术需求、技术采用和竞争趋势。

范围：

  • 全球白内障发病率和手术数量（目前估计值、预测值和5年预测值）
  • 双侧白内障同期手术的采用趋势
  • 老花眼、屈光不正矫正和屈光水晶体置换术的角色转变。
  • 按类型和地区对老花眼矫正型人工水晶体（PC-IOL）进行详细预测。
  • 各国/地区单视及微单视策略实施情形
  • 美国白内障和屈光医师的概况和临床决策
  • 报销趋势及其对手术方案和高端人工水晶体应用的影响。
  • 对新兴高端人工水晶体技术和产品改进的分析
  • 深入分析人工水晶体注射器市场及其在手术流程中的作用
  • 全球商业策略展望，包括 30 个主要国家的销售和分销网络。

这项综合分析清楚地展现了当前全球人工水晶体(IOL) 市场的市场状况以及成长机会所在。

简介目录

What's New:

The "2026 IOL Market Report" is our most comprehensive and strategically insightful edition to date, featuring deeper regional analysis, new technology intelligence, and broader evaluation of the structural forces reshaping the global cataract market.

This year's edition enhances all eight regional categories with a comprehensive recap of 2025, highlighting key events, competitive shifts, pricing dynamics, and market trends. In addition, a six-year revenue history (2019-2025) breaks out sales by monofocal, presbyopia-correcting, toric, and other IOLs to provide clearer visibility into segment-level growth and premium mix evolution.

The 2026 report also introduces new sections examining the growing use of artificial intelligence in PC-IOL design and its potential impact on performance; the advantages and limitations of distributor-based go-to-market strategies used by small- and mid-sized manufacturers (including identification of key distributors across all regions); emerging IOL materials such as SIBS-based platforms like Eyedeal; and broader market factors, including dry eye management to optimize IOL outcomes and the potential effect of an expected ophthalmic workforce shortage on cataract surgery volumes.

The "2026 IOL Market Report" delivers a comprehensive, data-driven view of the global intraocular lens market, combining detailed analysis of today's landscape with five-year forecasts designed to inform strategy, investment, and competitive positioning.

Built on Market Scope's proprietary models and deep industry insight, the report identifies the trends shaping demand, tracks shifts in technology adoption, and highlights the factors that will define success in an increasingly competitive and innovation-driven market.

The analysis segments the market across 11 distinct IOL categories-commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs- to provide a clear view of where growth is occurring and how the premium market continues to evolve.

In addition, the report profiles 40 leading companies, offering insight into their product portfolios, strategic positioning, competitive strengths, and future outlook to provide you with the intelligence needed to benchmark competitors and identify opportunities in the global IOL market.

Contents:

The "2026 IOL Market Report" provides an unprecedented global view of the cataract and intraocular lens market, spanning eight key regions and combining procedure demand, technology adoption, and competitive dynamics into a single, actionable analysis.

Coverage includes:

  • Global cataract incidence and surgical volume, with current estimates and five-year forecasts
  • Adoption trends for simultaneous bilateral cataract surgery
  • The evolving role of presbyopia, refractive error correction, and refractive lens exchange
  • Detailed forecasts for presbyopia-correcting IOLs (PC-IOLs) by type and region
  • Adoption of monovision and mini-monovision strategies by country/region
  • Profiles of US cataract and cataract/refractive surgeons and their clinical decision-making
  • Reimbursement trends and their impact on procedure mix and premium adoption
  • Analysis of emerging premium IOL technologies and product enhancements
  • Insights into the IOL injector market and its role in surgical workflow
  • A global view of commercial strategy, including sales and distribution coverage across 30 major countries

This integrated analysis provides a clear understanding of where the market stands today and where growth opportunities are emerging across the global IOL landscape.